Business Context and Reporting Period
This Form 8-K reports the results of the Boston Scientific Corporation 2025 Annual Meeting of Stockholders held on May 1, 2025. The meeting was conducted in a virtual format via live webcast.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Director Elections: All 10 director nominees were elected to the Board of Directors for a one-year term.
- Executive Compensation: Stockholders approved, on an advisory basis, the compensation of the Named Executive Officers.
- Auditor Ratification: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the 2025 fiscal year.
- Stockholder Proposal: Stockholders approved, on an advisory basis, the proposal titled "Support Simple Majority Vote."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the specific "Against" vote counts for directors David C. Habiger, Michael F. Mahoney, and John E. Sununu, which were notably higher than other nominees.
- Confirm the total number of shares represented at the meeting by summing For, Against, Abstain, and Broker Non-Votes.
- Review the full proxy statement for details on the "Support Simple Majority Vote" proposal and its implications for future governance.